StemCyte

About:

StemCyte is specialized in the development of umbilical cord blood stem cell transplantation and therapeutic products.

Twitter/X: stemcyte

Top Investors: Agility Capital, Peninsula Bank

Description:

StemCyte, Inc. operates as an umbilical cord blood stem cell transplantation and therapeutic products company. It provides cord blood products to transplant centers for life-threatening diseases. The company's products are used to treat patients suffering from various blood cancers, and immune and genetic disorders. StemCyte, Inc. was founded in 1997 and is headquartered in Covina, California. It operates umbilical cord blood storage facilities in California and Taiwan. The company has locations in the United States, India, and Taiwan.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Covina, California, United States

Founded Date:

1997-01-01

Founders:

Robert Chow

Number of Employees:

501-1000

Last Funding Date:

2010-11-22

IPO Status:

Private

Industries: